SAINT CHARLES, MO (June 10, 2021) – On June 10, U.S. International Trade Commission (ITC) affirmatively determined that the United States methionine industry is materially injured by reason of imports of methionine from France that are sold in the United States at less than fair value.
This final determination by the ITC is part of an investigation into methionine dumping in the U.S. In July 2020, Novus International, Inc. filed petitions requesting that the ITC and U.S. Department of Commerce investigate alleged illegal methionine dumping from Spain, France and Japan. Novus believed the U.S. methionine market experienced injury as a result of methionine products from those three countries being sold below market value.
In September 2020 the ITC commissioners made a preliminary determination in agreement with Novus’s concern – that the U.S. methionine industry has been or is being damaged by methionine dumping from Spain, France and Japan.
Identical to its preliminary determination, the latest ITC commissioners’ vote was unanimous and confirms part of its preliminary determination – specifically that methionine imports from France have caused material injury to the U.S. industry. The final determination with regards to imports from Spain and Japan is expected in August. Ed Galo, Novus vice president and chief commercial officer for Americas and EMEA, said today’s announcement validates the work his company has done for more than a year to bring these circumstances to light.
“Fair trade practices are essential to the long-term health of any industry. Submitting the antidumping petitions to the ITC and Commerce in July of 2020 was no small effort, and since then we have worked very hard to show the intentional imbalance in the U.S. methionine market. I congratulate the team for their hard work; it’s rewarding to see this positive outcome,” he said.
Mentioned in this news release: